{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-23-000048","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.874996+00:00","generated_at":"2026-06-10T08:07:48.873743+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iBio reports FY2023 net loss of $65M, nil revenue; audit opinion includes going concern","bullets":["Revenue $0 vs $1.9M in FY2022; net loss $65.0M, up $14.6M from prior year due to discontinued ops.","Operating expenses $29.3M, down 7% from $31.6M; cash and restricted cash $7.6M at June 30, 2023.","Audit opinion includes going concern qualification; NYSE American rule requires public announcement.","Credit agreement with Woodforest amended; maturity extended to Dec 31, 2023 or acceleration date.","Pending CDMO facility sale intended to repay loan and extend cash runway; no assurance of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-23-000048","json":"https://secwatch.observer/filing/0001420720-23-000048.json","markdown":"https://secwatch.observer/filing/0001420720-23-000048.md","text":"https://secwatch.observer/filing/0001420720-23-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000048/0001420720-23-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000048/ibio-20230927x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:07:48.873743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4b3833cc000d07b2ec0081b703071282038827a","claim":"iBio, Inc. reported financial results for fiscal year ended June 30, 2023.","evidence_excerpt":"On September 27, 2023, iBio, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000048/0001420720-23-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}